OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Buprenorphine Treatment for Opioid Use Disorder: An Overview
Matisyahu Shulman, Jonathan Wai, Edward V. Nunes
CNS Drugs (2019) Vol. 33, Iss. 6, pp. 567-580
Open Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

The recent trend of twin epidemic in the United States: a 10-year longitudinal cohort study of co-prescriptions of opioids and stimulants
Seungyeon Lee, Wenyu Song, David W. Bates, et al.
The Lancet Regional Health - Americas (2025) Vol. 44, pp. 101030-101030
Closed Access | Times Cited: 3

Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel
Lynn Kohan, Sudheer Potru, Antje M. Barreveld, et al.
Regional Anesthesia & Pain Medicine (2021) Vol. 46, Iss. 10, pp. 840-859
Open Access | Times Cited: 97

Novel Pharmacological Approaches to the Treatment of Depression
Elias Elias, Ariel Y. Zhang, Melissa T. Manners
Life (2022) Vol. 12, Iss. 2, pp. 196-196
Open Access | Times Cited: 48

Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder
Davida M. Schiff, Timothy C. Nielsen, Bettina B. Hoeppner, et al.
American Journal of Obstetrics and Gynecology (2021) Vol. 225, Iss. 4, pp. 424.e1-424.e12
Open Access | Times Cited: 51

Buprenorphine and its formulations: a comprehensive review
Salomon Poliwoda, Nazir Noor, Jack S. Jenkins, et al.
Health psychology research (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 31

Functional biomacromolecules-based microneedle patch for the treatment of diabetic wound
Chenyu Zhao, Zhaoqi Wu, B. Pan, et al.
International Journal of Biological Macromolecules (2024) Vol. 267, pp. 131650-131650
Closed Access | Times Cited: 7

A Practical Approach for the Management of the Mixed Opioid Agonist-Antagonist Buprenorphine During Acute Pain and Surgery
Nafisseh S. Warner, Matthew A. Warner, Julie L. Cunningham, et al.
Mayo Clinic Proceedings (2020) Vol. 95, Iss. 6, pp. 1253-1267
Open Access | Times Cited: 47

Buprenorphine precipitated opioid withdrawal: Prevention and management in the ED setting
Anthony Spadaro, Brit Long, Alex Koyfman, et al.
The American Journal of Emergency Medicine (2022) Vol. 58, pp. 22-26
Open Access | Times Cited: 24

Outcomes of a mobile medical unit for low-threshold buprenorphine access targeting opioid overdose hot spots in Chicago
Sarah Messmer, Abigail T. Elmes, Antonio D. Jimenez, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 150, pp. 209054-209054
Open Access | Times Cited: 16

Caring for Our Patients With Opioid Use Disorder in the Perioperative Period: A Guide for the Anesthesiologist
Antje M. Barreveld, Andrew Mendelson, Brittany Deiling, et al.
Anesthesia & Analgesia (2023) Vol. 137, Iss. 3, pp. 488-507
Open Access | Times Cited: 16

“You might be nice, but where you take me, they're not gonna be”: Preferences for field‐based post‐overdose interventions
Jenna van Draanen, Addy Adwell, Courteney Wettemann, et al.
Drug and Alcohol Review (2024) Vol. 43, Iss. 7, pp. 1865-1879
Open Access | Times Cited: 5

Serotonin therapies for opioid-induced disordered swallow and respiratory depression
Michael Frazure, In Morimoto, Nathan Fielder, et al.
Journal of Applied Physiology (2024) Vol. 136, Iss. 4, pp. 821-843
Closed Access | Times Cited: 4

Nalmefene Hydrochloride: Potential Implications for Treating Alcohol and Opioid Use Disorder
MeShell Green, Charles A. Veltri, Oliver Grundmann
Substance Abuse and Rehabilitation (2024) Vol. Volume 15, pp. 43-57
Open Access | Times Cited: 4

Current Treatments for Substance Use Disorders
A.A.B. Barros D'Sa, Andrew Gaddis, Eric C. Strain
Oxford University Press eBooks (2025), pp. 685-696
Closed Access

Association Between Buprenorphine Adherence Trajectories, Health Outcomes, and Health Care Costs Among Medicaid Enrollees
Olajumoke A. Olateju, Chijioke Okeke, Mina Shrestha, et al.
Journal of Addiction Medicine (2025)
Closed Access

Methadone Analgesia During Awake Craniotomy for a Patient With Chronic Pain on Buprenorphine: A Case Report
Danielle Isham, Trevor M. Sytsma, Anoop P. Patel, et al.
A&A Practice (2025) Vol. 19, Iss. 4, pp. e01957-e01957
Closed Access

Thematic Analysis of Reddit Content About Buprenorphine-naloxone Using Manual Annotation and Natural Language Processing Techniques
Rachel Graves, Jeanmarie Perrone, Mohammed Ali Al-Garadi, et al.
Journal of Addiction Medicine (2021) Vol. 16, Iss. 4, pp. 454-460
Open Access | Times Cited: 24

Feasibility and effectiveness of extended-release buprenorphine (XR-BUP) among correctional populations: a systematic review
Cayley Russell, Tony P. George, Nitin Chopra, et al.
The American Journal of Drug and Alcohol Abuse (2024) Vol. 50, Iss. 5, pp. 567-586
Open Access | Times Cited: 3

Lessons Learned from the Implementation of the Wake County, North Carolina EMS Medication for Opioid Use Disorder Program
Andrew Godfrey, Vicki L. Coles, Michael D. Lyons, et al.
Prehospital Emergency Care (2025), pp. 1-7
Closed Access

Barriers and facilitators to buprenorphine delivery: Results from a qualitative study of syringe services provider experiences
Sarah Philbrick, Jessica L. Smith, Lynn D. Wenger, et al.
Journal of Substance Use and Addiction Treatment (2025) Vol. 172, pp. 209670-209670
Closed Access

Role of Nanomedicine in Transforming Pharmacotherapy for Substance Use Disorder (SUD)
Akshata Y. Patne, Subhra Mohapatra, Shyam S. Mohapatra
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2025) Vol. 17, Iss. 2
Open Access

Reported patient experiences of extended-release buprenorphine for opioid dependence: a qualitative systematic review and thematic analysis
Juliet Miko Flam-Ross, Giulia Federica Zampini
Drugs Education Prevention and Policy (2025), pp. 1-11
Closed Access

Page 1 - Next Page

Scroll to top